Abstract:Iron deficiency is a widespread global health concern with varying prevalence rates across different regions. In developing countries, scarcity of food and chronic infections contribute to iron deficiency, while in industrialized nations, reduced food intake and dietary preferences affect iron status. Other causes that can lead to iron deficiency are conditions and diseases that result in reduced intestinal iron absorption and blood loss. In addition, iron absorption and its bioavailability are influenced by the composition of the diet. Individuals with increased iron needs, including infants, adolescents, and athletes, are particularly vulnerable to deficiency. Severe iron deficiency can lead to anemia with performance intolerance or shortness of breath. In addition, even without anemia, iron deficiency leads to mental and physical fatigue, which points to the fundamental biological importance of iron, especially in mitochondrial function and the respiratory chain. Standard oral iron supplementation often results in gastrointestinal side effects and poor compliance. Low-dose iron therapy seems to be a valid and reasonable therapeutic option due to reduced hepatic hepcidin formation, facilitating efficient iron resorption, replenishment of iron storage, and causing significantly fewer side effects. Elevated iron levels influence gut microbiota composition, favoring pathogenic bacteria and potentially disrupting metabolic and immune functions. Protective bacteria, such as bifidobacteria and lactobacilli, are particularly susceptible to increased iron levels. Dysbiosis resulting from iron supplementation may contribute to gastrointestinal disorders, inflammatory bowel disease, and metabolic disturbances. Furthermore, gut microbiota alterations have been linked to mental health issues. Future iron therapy should consider low-dose supplementation to mitigate adverse effects and the impact on the gut microbiome. A comprehensive understanding of the interplay between iron intake, gut microbiota, and human health is crucial for optimizing therapeutic approaches and minimizing potential risks associated with iron supplementation.

The Impacts of Iron Overload and Ferroptosis on Intestinal Mucosal Homeostasis and Inflammation

Iron overload induces colitis by modulating ferroptosis and interfering gut microbiota in mice

Mechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota Remodeling

The Role of Iron Homeostasis in Remodeling Immune Function and Regulating Inflammatory Disease

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects

Differentiation of intestinal stem cells toward goblet cells under systemic iron overload stress are associated with inhibition of Notch signaling pathway and ferroptosis

Iron Overload Protects from Obesity by Ferroptosis

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases

The influence of microbiota on ferroptosis in intestinal diseases

The Role of Ferroptosis in Inflammatory Bowel Disease: Mechanisms and Therapeutic Implications

Mechanism and intervention measures of iron side effects on the intestine

Investigation the mechanism of iron overload-induced colonic inflammation following ferric citrate exposure

Iron and Inflammatory Cytokines Synergistically Induce Colonic Epithelial Cell Ferroptosis in Colitis

Gut microbiota bridges the iron homeostasis and host health

Advances in Ferroptosis and Inflammatory Bowel Disease

The important role of ferroptosis in inflammatory bowel disease

Current iron therapy in the light of regulation, intestinal microbiome, and toxicity: are we prescribing too much iron?

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)

Dysregulation of Iron Metabolism in Cardiovascular Diseases: from Iron Deficiency to Iron Overload

Emerging Pathological Engagement of Ferroptosis in Gut Diseases

[Research Progress of Ferroptosis in Ulcerative Colitis]